66 related articles for article (PubMed ID: 1435941)
1. Malabsorption of antituberculosis medications by a patient with AIDS.
Berning SE; Huitt GA; Iseman MD; Peloquin CA
N Engl J Med; 1992 Dec; 327(25):1817-8. PubMed ID: 1435941
[No Abstract] [Full Text] [Related]
2. Diagnostic Accuracy of Therapeutic Drug Monitoring During Tuberculosis Treatment.
Anderson G; Vinnard C
J Clin Pharmacol; 2022 Oct; 62(10):1206-1214. PubMed ID: 35588142
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of oral antimycobacterials and dosing guidance for Mycobacterium avium complex treatment in cystic fibrosis.
Martiniano SL; Wagner BD; Brennan L; Wempe MF; Anderson PL; Daley CL; Anthony M; Nick JA; Sagel SD
J Cyst Fibros; 2021 Sep; 20(5):772-778. PubMed ID: 34030986
[TBL] [Abstract][Full Text] [Related]
4. Early antituberculosis drug exposure in hospitalized patients with human immunodeficiency virus-associated tuberculosis.
Schutz C; Chirehwa M; Barr D; Ward A; Janssen S; Burton R; Wilkinson RJ; Shey M; Wiesner L; Denti P; McIlleron H; Maartens G; Meintjes G
Br J Clin Pharmacol; 2020 May; 86(5):966-978. PubMed ID: 31912537
[TBL] [Abstract][Full Text] [Related]
5. Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis.
Abulfathi AA; Decloedt EH; Svensson EM; Diacon AH; Donald P; Reuter H
Clin Pharmacokinet; 2019 Sep; 58(9):1103-1129. PubMed ID: 31049868
[TBL] [Abstract][Full Text] [Related]
6. High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study).
Cresswell FV; Ssebambulidde K; Grint D; Te Brake L; Musabire A; Atherton RR; Tugume L; Muzoora C; Lukande R; Lamorde M; Aarnoutse R; Meya D; Boulware DR; Elliott AM
Wellcome Open Res; 2018; 3():83. PubMed ID: 30175245
[No Abstract] [Full Text] [Related]
7. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Nahid P; Dorman SE; Alipanah N; Barry PM; Brozek JL; Cattamanchi A; Chaisson LH; Chaisson RE; Daley CL; Grzemska M; Higashi JM; Ho CS; Hopewell PC; Keshavjee SA; Lienhardt C; Menzies R; Merrifield C; Narita M; O'Brien R; Peloquin CA; Raftery A; Saukkonen J; Schaaf HS; Sotgiu G; Starke JR; Migliori GB; Vernon A
Clin Infect Dis; 2016 Oct; 63(7):e147-e195. PubMed ID: 27516382
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of first-line antituberculosis drugs in HIV-infected children with tuberculosis treated with intermittent regimens in India.
Ramachandran G; Kumar AK; Bhavani PK; Kannan T; Kumar SR; Gangadevi NP; Banurekha VV; Sekar L; Ravichandran N; Mathevan G; Sanjeeva GN; Dayal R; Swaminathan S
Antimicrob Agents Chemother; 2015 Feb; 59(2):1162-7. PubMed ID: 25487804
[TBL] [Abstract][Full Text] [Related]
9. Review of evidence for measuring drug concentrations of first-line antitubercular agents in adults.
Wilby KJ; Ensom MH; Marra F
Clin Pharmacokinet; 2014 Oct; 53(10):873-90. PubMed ID: 25172553
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.
Bhatt NB; Barau C; Amin A; Baudin E; Meggi B; Silva C; Furlan V; Grinsztejn B; Barrail-Tran A; Bonnet M; Taburet AM;
Antimicrob Agents Chemother; 2014 Jun; 58(6):3182-90. PubMed ID: 24663014
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of rifampin in Peruvian tuberculosis patients with and without comorbid diabetes or HIV.
Requena-Méndez A; Davies G; Ardrey A; Jave O; López-Romero SL; Ward SA; Moore DA
Antimicrob Agents Chemother; 2012 May; 56(5):2357-63. PubMed ID: 22330931
[TBL] [Abstract][Full Text] [Related]
12. Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients.
Wilkins JJ; Langdon G; McIlleron H; Pillai G; Smith PJ; Simonsson US
Br J Clin Pharmacol; 2011 Jul; 72(1):51-62. PubMed ID: 21320152
[TBL] [Abstract][Full Text] [Related]
13. Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study.
Silva DR; Menegotto DM; Schulz LF; Gazzana MB; Dalcin PT
BMC Infect Dis; 2010 Mar; 10():54. PubMed ID: 20205952
[TBL] [Abstract][Full Text] [Related]
14. Safety, efficacy and pharmacokinetics of ritonavir 400mg/saquinavir 400mg twice daily plus rifampicin combined therapy in HIV patients with tuberculosis.
Rolla VC; da Silva Vieira MA; Pereira Pinto D; Lourenço MC; de Jesus Cda S; Gonçalves Morgado M; Ferreira Filho M; Werneck-Barroso E
Clin Drug Investig; 2006; 26(8):469-79. PubMed ID: 17163279
[TBL] [Abstract][Full Text] [Related]
15. Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients.
McIlleron H; Wash P; Burger A; Norman J; Folb PI; Smith P
Antimicrob Agents Chemother; 2006 Apr; 50(4):1170-7. PubMed ID: 16569826
[TBL] [Abstract][Full Text] [Related]
16. Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.
Gurumurthy P; Ramachandran G; Hemanth Kumar AK; Rajasekaran S; Padmapriyadarsini C; Swaminathan S; Bhagavathy S; Venkatesan P; Sekar L; Mahilmaran A; Ravichandran N; Paramesh P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4473-5. PubMed ID: 15504887
[TBL] [Abstract][Full Text] [Related]
17. Effect of sex and AIDS status on the plasma and intrapulmonary pharmacokinetics of rifampicin.
Conte JE; Golden JA; Kipps JE; Lin ET; Zurlinden E
Clin Pharmacokinet; 2004; 43(6):395-404. PubMed ID: 15086276
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic drug monitoring in the treatment of tuberculosis.
Peloquin CA
Drugs; 2002; 62(15):2169-83. PubMed ID: 12381217
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.
Burman WJ; Gallicano K; Peloquin C
Clin Pharmacokinet; 2001; 40(5):327-41. PubMed ID: 11432536
[TBL] [Abstract][Full Text] [Related]
20. The role of fluoroquinolones in tuberculosis today.
Berning SE
Drugs; 2001; 61(1):9-18. PubMed ID: 11217874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
